Christopher Anzalone, Arrowhead president and CEO

Wis­con­sin giv­ing Ar­row­head Phar­ma­ceu­ti­cals some ched­dar as their new man­u­fac­tur­ing site re­ceives sev­er­al mil­lion in state and lo­cal tax ben­e­fits

Ar­row­head Phar­ma­ceu­ti­cals is get­ting a leg up from Wis­con­sin of­fi­cials on a new build­ing project.

The com­pa­ny has out­lined a set of in­cen­tives that have be­come quite com­mon as states look to com­pete for new man­u­fac­tur­ing fa­cil­i­ties and the jobs they can cre­ate.

Ar­row­head is build­ing a new drug man­u­fac­tur­ing fa­cil­i­ty in Verona, WI, rough­ly 10 miles from Madi­son, that will have 125,000 square foot lab­o­ra­to­ry and of­fice fa­cil­i­ties to sup­port process de­vel­op­ment and an­a­lyt­i­cal ac­tiv­i­ties. It will al­so con­tain 160,000 square feet of man­u­fac­tur­ing space. Ar­row­head is no stranger to the Madi­son area as it cur­rent­ly has op­er­a­tions around in the state’s cap­i­tal.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.